Research / CBT / Fundamental state Inspectable configuration
State dimensions Filing 0001564590-21-058692 General Corporate
Debt relative to revenue 13th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.debt_to_revenue
31.12% · OPTIONAL · VALID
Capex intensity 31th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.72% · OPTIONAL · VALID
Operating cash generation 38th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
7.54% · OPTIONAL · VALID
Revenue growth 92th Own-history percentile · N=12
Evidence method Yoy · gp.fundamentals.revenue
30.41% · CORE · VALID
Inventory pressure 19th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
15.34% · OPTIONAL · VALID
Gross margin 69th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.gross_margin
23.44% · CORE · VALID
Operating margin 81th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.operating_margin
13.32% · CORE · VALID
R&D intensity 6th Own-history percentile · N=16
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.64% · OPTIONAL · VALID
SBC intensity 69th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.62% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 126.06%
Current 31.12%
Delta -94.94% Capex Intensity Increased
Previous 5.02%
Current 5.72%
Delta 0.70% Cash Generation Decreased
Previous 7.74%
Current 7.54%
Delta -0.20% Growth Decreased
Previous 77.03%
Current 30.41%
Delta -46.61% Inventory Pressure Decreased
Previous 53.11%
Current 15.34%
Delta -37.77% Margin Increased
Previous 23.34%
Current 23.44%
Delta 0.10% Profitability Decreased
Previous 14.61%
Current 13.32%
Delta -1.30% R And D Intensity Increased
Previous 1.31%
Current 1.64%
Delta 0.33% Sbc Intensity Decreased
Previous 0.65%
Current 0.62%
Delta -0.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.